Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ann Dermatol Venereol ; 129(2): 183-5, 2002 Feb.
Article in French | MEDLINE | ID: mdl-11937956

ABSTRACT

INTRODUCTION: Alarming hemangiomas can be successfully treated with corticosteroids. The risk of hypertension is poorly documented in this setting. We conducted a prospective study in infants with hemangiomas treated with orally administered prednisone. PATIENTS AND METHODS: Thirty-seven patients with rapidly growing complicated hemangiomas were enrolled between January 1998 and November 1999. Steroid dosages varied from 1 mg/kg/d to 5 mg/kg/d. Blood pressure measurements were performed first twice a month, then monthly at rest with a Critikon Dynamap device. Hypertension was defined as blood pressure superior to 110/60 mmHg, and borderline if superior to 110/60 mmHg on only one or two measurements. RESULTS: Increased blood pressure was found in seven infants (19 p. 100). One infant had hypertension requiring specific treatment and blood pressure was borderline on six patients at one or two occasions. Cardiac ultrasound examination was performed in five patients revealing two cases of myocardic hypertrophy, which regressed after stopping steroids and without relationship to hypertension. CONCLUSION: Even though the definition of hypertension in still arbitrary in infants, the measurement of blood pressure is necessary when steroid therapy is given for the treatment of hemangiomas. Blood pressure measurement can be difficult in very young children and overestimation is frequent if an inadequate device is used. The exact place of cardiac ultrasound remains to be defined in the management of alarming hemangiomas.


Subject(s)
Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Blood Pressure/drug effects , Hemangioma/drug therapy , Skin Neoplasms/drug therapy , Adrenal Cortex Hormones/administration & dosage , Age Factors , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/therapeutic use , Blood Pressure Determination , Echocardiography , Female , Humans , Hypertension/chemically induced , Hypertrophy, Left Ventricular/chemically induced , Infant , Male , Monitoring, Physiologic , Prednisone/administration & dosage , Prednisone/adverse effects , Prednisone/therapeutic use , Prospective Studies , Time Factors , Treatment Outcome
2.
Rev Med Interne ; 22(9): 877-80, 2001 Sep.
Article in French | MEDLINE | ID: mdl-11599190

ABSTRACT

INTRODUCTION: Ecthyma gangrenosum is a rare skin infection caused by gram negative bacteria. It involves immunocompromised patients, especially neutropenic patients, and can be easily diagnosed. EXEGESIS: We report a case of ecthyma gangrenosum without septicemia due to Pseudomonas aeruginosa in a myelodysplastic patient with severe neutropenia. Granulocyte growth factors adjunction was necessary in combination to antibiotics to obtain complete healing. CONCLUSION: In neutropenic patient, ecthyma gangrenosum due to Pseudomonas aeruginosa should be rapidly diagnosed to avoid septicemic complications. In the case of antibiotic treatment failure, granulocyte growth factors may be added. Frequent Pseudomonas aeruginosa infections justify bacteriologic survey to look for hospital contamination.


Subject(s)
Ecthyma/etiology , Neutropenia/complications , Pseudomonas Infections , Aged , Ecthyma/pathology , Female , Filgrastim , Follow-Up Studies , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Myelodysplastic Syndromes/complications , Pseudomonas Infections/drug therapy , Recombinant Proteins , Skin/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...